A study of improvement effects on physical functions by ingesting a food ingredient. - A study of improvement effects on physical functions by ingesting a food ingredient.

CPCC Company Limited0 sites60 target enrollmentJune 22, 2022

ConditionsElderly male/female subjects

Overview

Phase: 未知
Intervention: Not specified
Conditions: Elderly male/female subjects
Sponsor: CPCC Company Limited
Enrollment: 60
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

June 22, 2022

End Date

September 25, 2022

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

CPCC Company Limited

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•(1\) Subjects who use affecting health foods routinely (over 3 times a week), and have any difficulty in stopping use after the consent. (2\) Subjects who use the affecting medicines (International Standard as the 2022 Prohibited List of World Anti\-Doping Code: anabolic agents, hormonal peptides, growth factors, beta2\-agonists, and hormone/metabolism regulators), over 3 times a week, and have any difficulty in limiting use during this study. (3\) Subjects who have a habit of resistance exercises with over moderate, or other ones with over high intensity. (4\) Subjects who drink a lot of alcohol. (5\) Subjects who have been suffered severely from their motor function (e.g., fracture, tendon rupture and tone muscle) within a year before this study. (6\) Subjects with an impaired motor function. (7\) Subjects who use implantable medical electronic devices, such as a pacemaker. (8\) Subjects being prohibited from doing exercise, by a doctor. (9\) Subjects with previous/present medical history of serious diseases in heart, liver, kidney, lung, digestive organs, blood, and endocrine/nervous/metabolic systems. (10\) Subjects with drug and/or food allergy. (11\) Subjects who are now under another clinical study with a medicine/food, or take part in that within 4 weeks before this study, or will join that after the consent to join this study. (12\) Subjects who donated over 200 mL of their whole blood and/or blood components within a month before this study. (13\) Males who donated over 400 mL of their whole blood within the last 3 months before this study. (14\) Females who donated over 400 mL of their whole blood within the last 4 months before this study. (15\) Males who will be collected over 1200 mL in total of their blood within 12 months, before and in this study. (16\) Females who will be collected over 800 mL in total of their blood within 12 months, before and in this study. (17\) Subjects who have been determined as ineligible for participation, by the principal/sub investigator.